drugset / Trial / NCT01774851
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether the combination of MM-111 plus paclitaxel and trastuzumab is more effective than paclitaxel and trastuzumab alone
Timeline
- Start
- 2013-01
- Primary completion
- 2015-07
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MM-111 | Unknown | — | Intravenous |
| Background | Paclitaxel | Small molecule | — | Intravenous |
| Background | Trastuzumab | Monoclonal antibody | — | Intravenous |